Germany's ClinIT receives government grant
This article was originally published in Scrip
The German federal ministry for economics and technology has provided a six-figure grant to Freiburg-based ClinIT and the faculty for databases and information systems of the local Albert-Ludwigs University. The move was made within the Central Innovation Scheme for Medium-sized Businesses development programme. ClinIT intends to develop a new tool for the automatic analysis of data quality in clinical studies and thus optimise the existing scheme when such analysis is carried out for each project. The tool should provide project and data managers who have no specific programming skills with an opportunity to measure and control the quality of data and processes over large-volume libraries and databases, along with cost-effectiveness. ClinIT, which was founded in 2001, specialises in the development and supply of information systems for clinical trials.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.